The multi-step process required to discover and produce a personal neoantigen vaccine for a given patient is time consuming, costly, and inevitably restricted to targeting only a small subset of imperfectly predicted neoantigens, features which limit the therapeutic potential of the current generation of personal neoantigen cancer vaccines. Dionis Therapeutics seeks to revolutionize the personal cancer vaccine space by utilizing a proprietary approach.
View Top Employees from Dionis Therapeutics| Employees | 1 (1 on RocketReach) |
| Founded | 2022 |
| Industry | Biotechnology Research |
Looking for a particular Dionis Therapeutics employee's phone or email?
Dionis Therapeutics Questions
Ed Fritsch is the Founder and President of Dionis Therapeutics.
1 people are employed at Dionis Therapeutics.
Dionis Therapeutics is based in Concord, Massachusetts.
Top Dionis Therapeutics Employees
Related Companies
